"Currently, a number of tests are required to determine the specific chemical and physical properties that characterize raw materials and products," says Christina Vacca, chief executive officer of Aria. "These tests are time consuming, expensive, and/or require potentially dangerous reagents to prepare samples for testing. With Aria's process, we are able to perform a single test at a fraction of the cost and time and without the use of hazardous chemicals. One such use of the information generated by our technology is the ability to track changes in the samples that occur over time. "
In addition to the financial investment, Mark Smith, Entrepreneur-in- Residence from JumpStart's Acceleration Team, will be providing business development services to the company.
"Aria is yet another example of Northeast Ohio's strength in advanced technologies," Smith said. "We are excited about working with Chris to move the Aria technology closer to market acceptance."
This is JumpStart's 32nd investment in 24 companies. Other companies in JumpStart's portfolio include AcelleRX Therapeutics, AnalizaDx, FLX Micro, RSP Tooling, Synapse Biomedical, CardioInsight Technologies and Great Lakes Pharmaceuticals.
About Aria Analytics, Inc.
Aria Analytics is commercializing a novel platform analytical technology used to characterize liquids in industry and medical testing. This technology lowers both capital and operating costs per test. Prior to the availability of the Aria technology it was necessary to run a battery of tests on multiple laboratory instruments to obtain a profile of a specific sample. The Aria technology differentiates liquids by providing a unique acoustic signature during the drying process of the sample. Aria's mission is to provide sound analysis for industry and healthcare.
About JumpStart
'/>"/>
| SOURCE JumpStart Inc. Copyright©2007 PR Newswire. All rights reserved |